Meet our team at the University of California, San Francisco on September 12, 2024! We invite you to visit our team to learn about our complete iPSC platform and new cell manufacturing capabilities. Hope to see you soon.
Where: University of California, San Francisco – Mission Bay
Booth: TBD
When: September 9, 2024
Link: Coming Soon
About Applied StemCell, Inc.
ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATTTM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.
Media Contact
Pia Abola
Marketing Director, Applied StemCell, Inc.
pia.abola@appliedstemcell.com